NO973800L - Kjemokinreseptorer 88-2B£CKR-3| og 88C og deres antistoffer - Google Patents

Kjemokinreseptorer 88-2B£CKR-3| og 88C og deres antistoffer

Info

Publication number
NO973800L
NO973800L NO973800A NO973800A NO973800L NO 973800 L NO973800 L NO 973800L NO 973800 A NO973800 A NO 973800A NO 973800 A NO973800 A NO 973800A NO 973800 L NO973800 L NO 973800L
Authority
NO
Norway
Prior art keywords
chemokine receptors
antibodies
ckr
modulators
ligands
Prior art date
Application number
NO973800A
Other languages
English (en)
Other versions
NO973800D0 (no
Inventor
Patrick W Gray
Vicki L Schweickart
Carol J Raport
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO973800(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO973800D0 publication Critical patent/NO973800D0/no
Publication of NO973800L publication Critical patent/NO973800L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973800A 1995-12-20 1997-08-19 Kjemokinreseptorer 88-2B£CKR-3| og 88C og deres antistoffer NO973800L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/575,967 US6265184B1 (en) 1995-12-20 1995-12-20 Polynucleotides encoding chemokine receptor 88C
US08/661,393 US6268477B1 (en) 1995-12-20 1996-06-07 Chemokine receptor 88-C
PCT/US1996/020759 WO1997022698A2 (en) 1995-12-20 1996-12-20 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies

Publications (2)

Publication Number Publication Date
NO973800D0 NO973800D0 (no) 1997-08-19
NO973800L true NO973800L (no) 1997-10-20

Family

ID=24302427

Family Applications (2)

Application Number Title Priority Date Filing Date
NO973800A NO973800L (no) 1995-12-20 1997-08-19 Kjemokinreseptorer 88-2B£CKR-3| og 88C og deres antistoffer
NO20052202A NO327506B1 (no) 1995-12-20 2005-05-04 Renset og isolert polynukleotid, RNA-transkript, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et 88C-polypeptid, polynukleotid som koder for et 88C-polypeptid, renset og isolert polypeptid, antistoffprodukt, hybridom, hybridomcellelinje, biologisk funksjonell DNA-vektor, fremgangsmate for fremstilling av makak-88C-polypeptid, antistoffprodukt, fremgangsmate for a screene etter en modulator av HIV-infeksjon, fremgangsmate for a pavise HIV-infeksjon i celler og fremgangsmate for identifisering av en ligand som er i stand til a pavirke kjemokinreseptoren 88C.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20052202A NO327506B1 (no) 1995-12-20 2005-05-04 Renset og isolert polynukleotid, RNA-transkript, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et 88C-polypeptid, polynukleotid som koder for et 88C-polypeptid, renset og isolert polypeptid, antistoffprodukt, hybridom, hybridomcellelinje, biologisk funksjonell DNA-vektor, fremgangsmate for fremstilling av makak-88C-polypeptid, antistoffprodukt, fremgangsmate for a screene etter en modulator av HIV-infeksjon, fremgangsmate for a pavise HIV-infeksjon i celler og fremgangsmate for identifisering av en ligand som er i stand til a pavirke kjemokinreseptoren 88C.

Country Status (17)

Country Link
US (7) US6265184B1 (no)
EP (3) EP1870465B1 (no)
JP (4) JP3288384B2 (no)
CN (2) CN1827646A (no)
AT (2) ATE309349T1 (no)
AU (1) AU730463B2 (no)
BR (1) BR9607300A (no)
CA (1) CA2213331C (no)
CZ (1) CZ261097A3 (no)
DE (2) DE69635406T3 (no)
DK (2) DK1870465T3 (no)
ES (2) ES2255716T5 (no)
HU (1) HUP9801127A3 (no)
NO (2) NO973800L (no)
PL (2) PL192294B1 (no)
SK (1) SK112897A3 (no)
WO (1) WO1997022698A2 (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
US20040151719A1 (en) * 1995-06-06 2004-08-05 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) * 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
EP0847452B1 (en) * 1995-06-07 2009-04-01 Progenics Pharmaceuticals, Inc. Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU1834197A (en) * 1996-01-30 1997-08-22 National Institutes Of Health, The Cells expressing both human cd4 and cxcr4
CA2247989C (en) * 1996-03-01 2010-12-14 Euroscreen S.A. C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
US7858298B1 (en) * 1996-04-01 2010-12-28 Progenics Pharmaceuticals Inc. Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
WO1997037005A1 (en) 1996-04-02 1997-10-09 Progenics Pharmaceuticals, Inc. Method for preventing hiv-1 infection of cd4+ cells
US6271347B1 (en) * 1996-04-26 2001-08-07 Merck & Co., Inc. Eosinophil eotaxin receptor
CA2252432A1 (en) * 1996-04-26 1997-11-06 Incyte Pharmaceuticals, Inc. Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
CA2252850A1 (en) * 1996-04-26 1997-11-06 Merck & Co., Inc. Eosinophil eotaxin receptor
US6258527B1 (en) 1996-05-20 2001-07-10 The Aaron Diamond Aids Research Center Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
US5939320A (en) * 1996-05-20 1999-08-17 New York University G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
EP0975749A2 (en) * 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
US20040086528A1 (en) * 1996-06-14 2004-05-06 Progenics Pharmaceuticals, Inc. Uses of a chemokine receptor for inhibiting HIV-1 infection
US6057102A (en) * 1996-08-08 2000-05-02 The Aaron Diamond Aids Research Center HIV coreceptor mutants
US6388055B1 (en) 1996-10-03 2002-05-14 Smithkline Beecham Corporation Mouse CC-CKR5 receptor polypeptide
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
US6153431A (en) * 1997-05-30 2000-11-28 Fond Mondiale Rech & Prev Sida Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
US6465237B1 (en) * 1997-07-01 2002-10-15 Millennium Pharmaceuticals, Inc. Cloning and characterization of a human adenylyl cyclase
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6204024B1 (en) 1997-09-12 2001-03-20 Akzo Nobel N.V. CCR5 RNA transcription based amplification assay
US6287805B1 (en) 1998-03-20 2001-09-11 Millennium Pharmaceuticals, Inc. Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor
CA2235420A1 (en) * 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US20080015348A1 (en) * 1998-12-16 2008-01-17 Progenics Pharmaceuticals, Inc. Nucleic acids encoding polypeptides of anti-CCR5 antibodies
US20040228869A1 (en) * 1998-12-16 2004-11-18 Progenics Pharmaceuticals, Inc. Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto
JP4712975B2 (ja) 1999-01-12 2011-06-29 ケンブリッジ エンタープライズ リミティド 炎症反応を阻害又は増強するための組成物及び方法
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
WO2001058915A2 (en) * 2000-02-09 2001-08-16 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
WO2002014532A2 (en) 2000-08-15 2002-02-21 Millennium Pharmaceuticals, Inc. Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10
US7138119B2 (en) * 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7175988B2 (en) * 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7060273B2 (en) * 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20030104496A1 (en) * 2001-11-30 2003-06-05 Cytokinetics, Inc. Novel motor protein of P. falciparum and methods for its use
US7393934B2 (en) * 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
EP2075256A2 (en) 2002-01-14 2009-07-01 William Herman Multispecific binding molecules
RU2360923C2 (ru) * 2002-01-18 2009-07-10 Займоджинетикс, Инк. Новый лиганд рецептора цитокина zcytor17
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
EP2272946B9 (en) 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Minicell compositions and methods
US7094848B2 (en) * 2003-05-13 2006-08-22 Exxonmobil Chemical Patents Inc. Olefin polymerization catalyst system
WO2005105841A2 (en) * 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
WO2005106492A2 (en) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
US8119790B2 (en) 2004-10-29 2012-02-21 Topigen Pharmaceuticals Inc. Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
JP2009514790A (ja) * 2005-07-22 2009-04-09 プロジェニクス・ファーマスーティカルズ・インコーポレイテッド Ｈｉｖ−１−感染患者におけるウイルス負荷を減少させる方法
AU2007207544A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
US20080283557A1 (en) * 2007-05-17 2008-11-20 Julianne Desautels Spout for food stuff container
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
US20090074766A1 (en) * 2007-09-14 2009-03-19 Ketas Thomas J Methods of inhibiting HIV-2 infection
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2691530B1 (en) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
DE102013200909A1 (de) * 2013-01-22 2014-07-24 Robert Bosch Gmbh Brennstoffeinspritzanlage mit einer Brennstoff führenden Komponente, einem Brennstoffeinspritzventil und einem Verbindungselement
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
CN106405067B (zh) * 2016-08-31 2018-03-30 徐州医科大学 一种基于全细胞的药物靶点停留时间的检测方法
JP6378735B2 (ja) * 2016-11-09 2018-08-22 本田技研工業株式会社 スイッチユニット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886742A (en) 1987-06-15 1989-12-12 Coulter Corporation Enzyme immunoassay for detecting HIV antigens in human sera
US4888920A (en) 1988-08-24 1989-12-26 Marulic Walter J Gutter anti-clogging device
US5215915A (en) 1991-04-16 1993-06-01 Duke University Cloned gene encoding rat d1b dopamine receptor
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
EP1146122A3 (en) 1995-06-06 2003-12-03 Human Genome Sciences, Inc. Human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
EP0815137A4 (en) 1995-06-06 1998-08-05 Human Genome Sciences Inc HUMAN G-PROTEIN CHEMOKIN RECEPTOR HDGNR10
US6512103B1 (en) 1995-12-08 2003-01-28 Schering Corporation Mammalian chemokine reagents
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
AU1750497A (en) 1996-01-17 1997-08-11 Progenics Pharmaceuticals, Inc. Compounds capable of inhibiting hiv-1 infection
CA2247989C (en) 1996-03-01 2010-12-14 Euroscreen S.A. C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
US5939320A (en) 1996-05-20 1999-08-17 New York University G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
EP0975749A2 (en) 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
AU3390297A (en) 1996-06-14 1998-01-07 Aaron Diamond Aids Research Center, The Uses of a chemokine receptor for inhibiting hiv-1 infection
US5994515A (en) * 1996-06-25 1999-11-30 Trustees Of The University Of Pennsylvania Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same

Also Published As

Publication number Publication date
EP1870465A3 (en) 2008-04-23
DK0811063T3 (da) 2006-04-10
US20040230037A1 (en) 2004-11-18
CA2213331C (en) 2011-09-27
EP1642975A2 (en) 2006-04-05
CN1222617C (zh) 2005-10-12
CN1183805A (zh) 1998-06-03
US6265184B1 (en) 2001-07-24
ES2255716T5 (es) 2014-03-21
DK1870465T3 (da) 2010-05-17
ATE309349T1 (de) 2005-11-15
ES2341371T3 (es) 2010-06-18
EP0811063B9 (en) 2014-04-23
CA2213331A1 (en) 1997-06-26
US6797811B1 (en) 2004-09-28
WO1997022698A3 (en) 1997-09-12
HUP9801127A2 (hu) 1998-08-28
EP0811063B2 (en) 2013-12-04
AU1689297A (en) 1997-07-14
HUP9801127A3 (en) 2000-12-28
SK112897A3 (en) 1998-07-08
CN1827646A (zh) 2006-09-06
DE69635406D1 (de) 2005-12-15
EP1642975A3 (en) 2006-04-12
JP2009065976A (ja) 2009-04-02
EP1870465A2 (en) 2007-12-26
NO973800D0 (no) 1997-08-19
US20080032336A1 (en) 2008-02-07
US6268477B1 (en) 2001-07-31
MX9706316A (es) 1997-11-29
NO20052202L (no) 1997-10-20
DE69635406T3 (de) 2014-04-24
AU730463B2 (en) 2001-03-08
DE69638128D1 (de) 2010-04-01
US20050260565A1 (en) 2005-11-24
WO1997022698A2 (en) 1997-06-26
EP0811063B1 (en) 2005-11-09
PL192294B1 (pl) 2006-09-29
EP1870465B1 (en) 2010-02-17
BR9607300A (pt) 1997-11-25
CZ261097A3 (cs) 1998-06-17
JP2001264324A (ja) 2001-09-26
PL321937A1 (en) 1998-01-05
US7662548B2 (en) 2010-02-16
JPH11503028A (ja) 1999-03-23
ES2255716T3 (es) 2006-07-01
PL192071B1 (pl) 2006-08-31
EP0811063A2 (en) 1997-12-10
JP2001029089A (ja) 2001-02-06
DE69635406T2 (de) 2006-08-03
NO20052202D0 (no) 2005-05-04
JP3288384B2 (ja) 2002-06-04
ATE458052T1 (de) 2010-03-15
NO327506B1 (no) 2009-07-27
US20020150888A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
NO973800L (no) Kjemokinreseptorer 88-2B£CKR-3| og 88C og deres antistoffer
NO961115L (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
DK1129190T3 (da) Human TSLP DNA og polypeptider
IL115792A0 (en) Al-1 neurothophic factor
ATE291585T1 (de) Traf-inhibitoren
DE3761072D1 (de) Blendenanordnung zur optoelektronischen abtastung von vorlagen.
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
ATE285474T1 (de) Haemophilus adhäsionsproteinen
IL159998A0 (en) Autologous t-cell vaccines materials and methods
FR2780416B1 (fr) Procede industriel de production de proteines heterologues chez e. coli et souches utiles pour le procede
DE19680416D2 (de) Reststoffaufspaltungsverfahren zur Wiedergewinnung von Sekundärrohstoffen
FR2709132B1 (fr) Fragment d'ADN portant le gène codant pour l'enzyme de fragmentation du N-acétylhéparosane et les séquences adjacentes permettant son expression, enzyme recombinée et son utilisation.
DE59611293D1 (de) Protein mit dnase-aktivität
FR2646606B1 (fr) Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
WO2000037492A3 (en) Human hepatoma-derived growth factor homologous (huhdgfh) ____
WO2001021794A3 (en) Smad associating polypeptides
DE58906674D1 (de) Verfahren zur Auswahl produktiver, Aminosäuren ausscheidender Stämme von Mikroorganismen.
FR2644176B1 (fr) Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
BR9502394A (pt) Aperfeiçoamento de processo de obtenção de placas de fibrocimento.
WO2003002611A3 (de) Fusionsproteine, verfahren zu deren herstellung und deren verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application